MetLife, Inc. $MET Shares Acquired by Sei Investments Co.

Posted by on Jul 26th, 2026

Sei Investments Co. lifted its position in MetLife, Inc. (NYSE:MET – Free Report) by 61.6% during the 1st quarter, Holdings Channel.com reports. The fund owned 908,052 shares of the financial services provider’s stock after acquiring an additional 346,107 shares during the period. Sei Investments Co.’s holdings in MetLife were worth $64,219,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MET. Vanguard Group Inc. lifted its position in MetLife by 12.1% during the 4th quarter. Vanguard Group Inc. now owns 72,555,335 shares of the financial services provider’s stock worth $5,727,518,000 after acquiring an additional 7,805,814 shares during the period. Pzena Investment Management LLC increased its holdings in shares of MetLife by 22.9% in the fourth quarter. Pzena Investment Management LLC now owns 11,883,338 shares of the financial services provider’s stock valued at $938,071,000 after purchasing an additional 2,211,315 shares during the period. Norges Bank purchased a new position in shares of MetLife in the fourth quarter worth about $639,986,000. Invesco Ltd. lifted its holdings in shares of MetLife by 2.6% during the fourth quarter. Invesco Ltd. now owns 7,012,198 shares of the financial services provider’s stock worth $553,543,000 after purchasing an additional 176,811 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of MetLife by 2.5% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,201,175 shares of the financial services provider’s stock worth $410,581,000 after purchasing an additional 126,098 shares during the period. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

NYSE MET opened at $94.67 on Friday. The stock has a market capitalization of $60.91 billion, a price-to-earnings ratio of 18.35, a PEG ratio of 0.72 and a beta of 0.78. The stock has a 50-day moving average of $87.27 and a 200 day moving average of $79.55. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a twelve month low of $67.33 and a twelve month high of $94.86.

MetLife (NYSE:MET – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The financial services provider reported $2.42 EPS for the quarter, beating the consensus estimate of $2.27 by $0.15. The company had revenue of $14.18 billion for the quarter, compared to analyst estimates of $19.49 billion. MetLife had a return on equity of 22.60% and a net margin of 4.66%.MetLife’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same period last year, the company earned $1.96 earnings per share. Sell-side analysts anticipate that MetLife, Inc. will post 9.89 EPS for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be given a dividend of $0.5925 per share. The ex-dividend date is Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a dividend yield of 2.5%. MetLife’s dividend payout ratio (DPR) is 45.93%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Jefferies Financial Group increased their price target on shares of MetLife from $97.00 to $103.00 and gave the stock a “buy” rating in a report on Friday, July 10th. UBS Group upped their price objective on shares of MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Keefe, Bruyette & Woods increased their price objective on shares of MetLife from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Monday, July 13th. Evercore set a $96.00 target price on shares of MetLife in a report on Thursday, April 9th. Finally, Morgan Stanley boosted their target price on shares of MetLife from $93.00 to $103.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $100.50.

Check Out Our Latest Analysis on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.